HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA reform act

This article was originally published in The Rose Sheet

Executive Summary

FDA reform act: President Clinton signs the "FDA Modernization Act" into law Nov. 21 at a White House bill signing ceremony. Clinton praised the measure as a "model" for policy makers who must "clearly define the public interest and then change the way we pursue it." He noted that three years ago he would have "taken odds" against signing the bipartisan reform measure into law. Vice President Gore and HHS Secretary Donna Shalala also spoke at the ceremony. The FDA reform bill passed the House and Senate Nov. 9, after two years of work...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004865

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel